Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 114.09M
March 31, 2026 114.02M
December 31, 2025 74.34M
September 30, 2025 74.34M
June 30, 2025 74.26M
March 31, 2025 74.05M
December 31, 2024 70.67M
September 30, 2024 67.56M
June 30, 2024 67.43M
March 31, 2024 58.69M
September 30, 2023 28.06M
June 30, 2023 28.05M
March 31, 2023 27.87M
June 30, 2022 14.20M
March 31, 2022 14.20M
December 31, 2021 14.20M
September 30, 2021 14.19M
June 30, 2021 14.19M
March 31, 2021 14.15M
December 31, 2020 8.723M
September 30, 2020 6.890M
June 30, 2020 6.890M
March 31, 2020 6.765M
December 31, 2019 6.739M
September 30, 2019 6.739M
Date Value
June 30, 2019 6.739M
March 31, 2019 6.734M
December 31, 2018 6.733M
September 30, 2018 6.733M
June 30, 2018 5.633M
March 31, 2018 5.51M
December 31, 2017 5.51M
September 30, 2017 5.502M
June 30, 2017 5.502M
March 31, 2017 5.502M
December 31, 2016 5.502M
September 30, 2016 5.501M
June 30, 2016 5.501M
March 31, 2016 5.501M
December 31, 2015 5.50M
September 30, 2015 5.50M
June 30, 2015 5.497M
March 31, 2015 5.487M
December 31, 2014 5.488M
September 30, 2014 5.488M
June 30, 2014 5.470M
March 31, 2014 5.417M
December 31, 2013 3.841M
September 30, 2013 3.842M
June 30, 2013 3.462M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 13.38M
MiMedx Group, Inc. 145.72M
ABVC BioPharma, Inc. 25.77M
Enovis Corp. 57.67M
Edwards Lifesciences Corp. 576.60M